PPA
TLIS

Parametric Portfolio Associates’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Parametric Portfolio Associates’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$196K Buy
9,261
+4,198
+83% +$145K ﹤0.01% 3448
2021
Q4 		$305K Sell
5,063
-135
-3% -$10.1K ﹤0.01% 3284
2021
Q3 		$487K Buy
5,198
+1,832
+54% +$244K ﹤0.01% 3123
2021
Q2 		$557K Buy
3,366
+591
+21% +$100K ﹤0.01% 3037
2021
Q1 		$535K Buy
+2,775
New +$692K ﹤0.01% 3475

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.3B AUM 62.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return